Traditional Chinese medicine drug for eliminating hepatitis B virus

Abstract

The invention discloses a traditional Chinese medicine drug for eliminating hepatitis B virus. The traditional Chinese medicine drug comprises the following raw materials in parts by weight: 4-7 parts of Chinese angelica, 3-6 parts of radix curcumae, 3-6 parts of bear gall powder, 3-6 parts of liquorice, 7-10 parts of radix isatidis, 9-12 parts of radix paeoniae alba, 7-10 parts of lucid ganoderma, 3-6 parts of bitter gourd, 2-5 parts of flos chrysanthemi, 3-6 parts of schisandra chinensis, 4-7 parts of orange peel, 9-11 parts of rhizoma dioscoreae, 3-6 parts of poria cocos, 3-5 parts of ligusticum wallichii, 3-6 parts of lycium barbarum, 3-6 parts of gorgon euryale seed, 9-12 parts of Chinese date, 2-5 parts of stevia rebaudian and 3-6 parts of radix bupleuri. The traditional Chinese medicine drug is a natural pure traditional Chinese medicine and has important functions of soothing the liver and promoting bile secretion, relieving liver qi depression and liver depression transforming into fire, clearing heat and removing toxin and restoring liver functions, avoids damage to the liver and liver cells and is safe and healthy to use. The DNA replication of hepatitis B virus is reduced to zero; and the traditional Chinese medicine drug is safe and healthy, can completely overcome the shortcomings of western medicine treatment of hepatitis B virus and deserves large-area application and popularization.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine for removing hepatitis B virus. Background technique [0002] There are nearly 100 million people with hepatitis B in our country, and more than 10,000 people die from liver cancer every year. When a person suffers from hepatitis B, there are very few people who can recover on their own. In the cells, some people have strong immunity, the virus is relatively stable, and there is no damage to the human liver, so there is no need for treatment. But for people with weak immunity, the virus will replicate in the body. When the amount of the virus reaches a certain level, the virus will destroy the liver cells and make the liver cells wither, thereby causing liver fibrosis (cirrhosis) and further development become liver cancer. In order to control the virus, Western medicine is generally used to treat the disease, such as interfe...

AI Technical Summary

Problems solved by technology

Adefovir controls protease to inhibit virus replication. Since adefovir inhibits protease, of course it has an impact on the synthesis of other enzymes. Long-term use is harmful to patients.